| 2 | Relation between bevacizumab dose intensity and high-grade glioma survival:a retrospective study in two large cohorts显示文摘Bevacizumab is one of the rare drugs that could improve high-grade glioma outcome after failure of chemoradiotherapy.However,to date,there is no biomarker predictive for efficacy of bevacizumab therapy in terms of survival improvement for patients with high- | Lorgis V Maura G Coppa G Hassani K Taillandier L Chauffert B Apetoh L Ladoire S Ghiringhelli F | 2012 | 中国神经肿瘤杂志2012，10，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员